# DeepCardio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepcardio

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.deepcardio.com
- Total disclosed funding: $3.4M
- Latest round: Series A (Feb 17, 2022)
- Investors on record: 2

## About

Based in Seoul, South Korea, and founded in 2020, DeepCardio Inc. is a research and technology company that focuses on utilising artificial intelligence. Their primary specialization lies in the early detection of heart diseases by analysing electrocardiogram (ECG) signals through AI-powered algorithms. The company was co-founded by Wonik Choi (CEO), Sang-Chul Lee (CTO), Dae-Hyeok Kim, and Yong-Soo Baek. In February 2022, DeepCardio Inc. raised KRW 4 billion in series A funding from investors DAYLI Partners and Softbank Ventures Asia. 

The company specializes in developing AI-based cardiac diagnostics technology, targeting the prediction of arrhythmias during normal sinus rhythms. They are actively engaged in the development of a deep-learning method for predicting atrial fibrillation, which aids in diagnosing patients who have experienced strokes of unknown cause. Their product line encompasses a range of offerings, including SmartECG-AF, SmartECG-AGE, SmartECG-EF, SmartECG-Stroke, and more.

## Funding rounds

- Series A, Feb 17, 2022, $3.4M — SBVA, DAYLI Partners

## Investors

- SBVA (https://capitalatlas.ai/funds/sbva) — Series A
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series A